BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Court Denies Preliminary Injunction Motion Against Ariosa Diagnostics, Inc.


7/9/2012 11:00:52 AM

SAN JOSE, Calif., July 6, 2012 /PRNewswire/ -- Ariosa Diagnostics, a molecular diagnostics company, announced today that the United States District Court for the Northern District of California denied the preliminary injunction motion filed against Ariosa Diagnostics by Sequenom, Inc. In its preliminary injunction motion, Sequenom sought to enjoin Ariosa Diagnostics from offering or selling its Harmony Prenatal Test, pending the ultimate resolution of the litigation between Ariosa Diagnostics and Sequenom. "Ariosa Diagnostics has vigorously opposed Sequenom's drastic attempt to bar Ariosa from competing with our Harmony Prenatal Test, and we feel pleased and vindicated by the Court's order denying Sequenom's preliminary injunction motion," said Dr. Ken Song, Ariosa Diagnostics' Chief Executive Officer.

(Logo: http://photos.prnewswire.com/prnh/20120326/NY75864LOGO )

About Ariosa Diagnostics (formerly Aria Diagnostics)

Ariosa Diagnostics, Inc. is a molecular diagnostics company committed to providing safe, highly accurate and affordable prenatal tests for maternal and fetal health. Led by an experienced team, Ariosa is using its proprietary technology to perform a directed analysis of cell-free DNA in blood. Ariosa's simple blood test equips pregnant women and their healthcare providers with reliable information to make decisions regarding their health, without creating unnecessary stress or anxiety.

The company began operations in 2010 and is headquartered in San Jose, Calif. For more information, visit www.ariosadx.com.

SOURCE Ariosa Diagnostics, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES